Managing the risks associated with using biomedical ethics advice

被引：1
作者：
Eaton, Margaret L. [1 ]
机构：
[1] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA
来源：
JOURNAL OF BUSINESS ETHICS | 2008年 / 77卷 / 01期
关键词：
biomedical ethics; bioscience industry; biotechnology; business ethics; ethics; pharmaceutical;
D O I：
10.1007/s10551-006-9296-x
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
This paper discusses the criticisms that exist about corporate use of ethics advice by bioscience companies and offers suggestions on how ethics advisors can be used so as to maximize their utility and avoid the criticism.
引用
收藏
页码：99 / 109
页数：11
相关论文
共 29 条
[1]  
Angell MarciaM.D., 2004, The Truth About Drug Companies: How They Deceive Us and What To Do About It
[2]  
Avorn J., 2004, Powerful Medicines. The Benefits, Risks
[3]  
BARON D, 2005, BUSINESS ENV, P543
[4]  
BERENBEIM RE, 1999, R124399R
[5]  
BOYCE N, 2001, ETHICS SALE
[6]  
BROWER V, 1999, BIOTECH EMBRACES BIO
[7]  
Cohen H, 2002, SCIENTIST, V16, P44
[8]  
DEYO A, 2005, AM MANAGEMENT ASS
[9]  
EATON M, 2004, ETHICS BUSINESS BIOS, P490
[10]  
EATON M, 2005, BIOINDUSTRY ETHICS, P219
123